Jim Cornall

biotech

Base to Base biotech podcast 52: Ketamine for depression, and a new company in the kidney disease space

biotech

Excalipoint Therapeutics launches with $68.7m to develop T-Cell engager therapies

biotech

FDA clearance for refractory gout treatment

biotech

Earendil Labs raises $787m to scale AI-driven biologics discovery and development

biotech

Researchers design drug capable of reversing cognitive decline in Alzheimer’s disease

biotech

Shingles vaccine cuts risk of serious cardiac events

biotech

Initial data suggest favourable safety profile for Alzheimer’s drug

biotech

Positive results from second-line metastatic breast cancer trial